
    
      This is a single center, prospective, randomized,controlled study to compare the clinical
      efficacy of double filtration plasmapheresis (DFPP) combined with intravenous
      cyclophosphamide (IV-CTX) pulse therapy versus IV-CTX pulse therapy in patients with
      antineutrophil cytoplasmic autoantibody associated glomerulonephritis(AAGN).
    
  